The mechanism by which GLP-1 agonists reduce alcohol intake in humans is currently unknown, though a recent RCT reported reduced alcohol cue reactivity in the nucleus accumbens (NAc), a key region associated with alcohols rewarding properties, after treatment with the GLP-1 agonist Exenatide 11
A licensed provider reviews your history and determines what's appropriate for you
This is one of the most compelling reasons to try tirzepatide
Leggio and his colleagues noted that, compared with other GLP-1 receptor agonists, semaglutide is more potent, has a higher affinity for its receptor, and is longer acting
Those brand-name finished drug products went through full FDA review for safety, effectiveness, quality, and manufacturing consistency